Wolfgang Miesbach/LinkedIn
Dec 19, 2025, 11:00
Gene Therapy for Hemophilia: New WFH Booklet and Webinar Released
World Federation of Hemophilia/Fédération mondiale de l’hémophilie posted on LinkedIn:
”Just released.
The WFH’s new educational resources on genetic technologies for hemophilia, including a booklet and a recorded webinar, explain gene editing and how it compares to other genetic technologies in clear, simple terms.
Learn more here.”
Title: Qualification Criteria of Gene Therapy for Haemophilia-Opinion of the EAHAD Gene Therapy Working Group
Authors: Wolfgang Miesbach, Ana Boban, Pratima Chowdary, Michiel Coppens, Victor Jimenez-Yuste, Robert Klamroth, Greta Mulders, Miguel Crato, Flora Peyvandi

Stay updated with Hemostasis Today.
Ana Boban
bleeding disorders
EAHAD
EAHAD Gene Therapy Working Group
European Association for Haemophilia and Allied Disorders
Flora Peyvandi
Gene therapy
Greta Mulders
haemophilia
Health
Hematology
Hemophilia
hemophilia gene therapy
Hemostasis
Hemostasis Today
Medicine
Michiel Coppens
Miguel Crato
Pratima Chowdary
Robert Klamroth
thrombosis
Víctor Jiménez-Yuste
WFH
Wolfgang Miesbach
World Federation of Hemophilia
-
Feb 20, 2026, 17:35Wolfgang Miesbach: Plasma FIX Is Only Part of the Story In Haemophilia B
-
Feb 20, 2026, 17:27Sheharyar Raza: Examining Guideline Discordance in Evidence-Based Apheresis Recommendations
-
Feb 20, 2026, 17:23Barbara Mora: Newly Discovered EPO Gene Intronic Variant as a Cause of Congenital Erythrocytosis
-
Feb 20, 2026, 16:48Miguel Brito: Newborn Screening and Challenges in Follow-Up Care for Sickle Cell Disease in Angola
-
Feb 20, 2026, 16:41Uche Kennedy: Hemophilia Care Needs Systems Reform, Not Short-Term Fixes
-
Feb 20, 2026, 16:33Sonal Sonu: Real Clinical Maturity is Knowing When to Stop
-
Feb 20, 2026, 16:27Clear Recommendations for Daily Management and Family Support in Hemophilia A – WFH
-
Feb 20, 2026, 15:56Alan Nurden: Highlighting the Role of Activated Platelets in Heart and Kidney Complications of Diabetes
-
Feb 20, 2026, 15:51Domenico Girelli: Continuing Commitment to Rare Disease Research